Showing results (231-240 of 579) with videos related to

Sort By:
Pageof 58
Experimental Hematology & Oncology|January 16, 2024
Outcomes of allogeneic hematopoietic stem cell transplantation in R/R DLBCL patients with failure of CAR-T therapyMengya Cong, Sicheng Ai, Liqing Kang, et al.
British Journal of Pharmacology|February 20, 2021
Emerging role of RNA interference in immune cells engineering and its therapeutic synergism in immunotherapyMasuma Akter Monty, Md Ariful Islam, Xu Nan, et al.
Plos One|January 28, 2014
Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growthHaixia Zhou, Yue Ge, Lili Sun, et al.
Biomarker Research|April 24, 2020
TBL1XR1 mutation predicts poor outcome in primary testicular diffuse large B-cell lymphoma patientsXinfeng Wang, Xiaoyu Xu, Wenzhi Cai, et al.
Leukemia Research|May 27, 2017
Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemiaBin Gu, Xiaojin Wu, Guanghua Chen, et al.
International Journal of Hematology|January 29, 2021
Characteristics and transplant outcome of myeloid sarcoma: a single-institute studyMeng Shan, Yutong Lu, Menglu Yang, et al.
International Journal of Hematology|March 14, 2014
Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemiaLimin Liu, Yanming Zhang, Zhengming Jin, et al.
Annals of Hematology|May 17, 2024
Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemiaTong Cui, Huiyu Li, Shiyuan Zhou, et al.
Molecular Cytogenetics|March 7, 2017
Multiple <i>MYO18A</i>-<i>PDGFRB</i> fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11)Guangying Sheng, Zhao Zeng, Jinlan Pan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2018
Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete RemissionJia Chen, Lingyi Yang, Yi Fan, et al.
Pageof 58